147 related articles for article (PubMed ID: 12632071)
1. Protein kinase Calpha regulates Ets1 transcriptional activity in invasive breast cancer cells.
Lindemann RK; Braig M; Ballschmieter P; Guise TA; Nordheim A; Dittmer J
Int J Oncol; 2003 Apr; 22(4):799-805. PubMed ID: 12632071
[TBL] [Abstract][Full Text] [Related]
2. Ets1 is an effector of protein kinase Calpha in cancer cells.
Vetter M; Blumenthal SG; Lindemann RK; Manns J; Wesselborg S; Thomssen C; Dittmer J
Oncogene; 2005 Jan; 24(4):650-61. PubMed ID: 15531915
[TBL] [Abstract][Full Text] [Related]
3. Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells.
Lindemann RK; Braig M; Hauser CA; Nordheim A; Dittmer J
Biochem J; 2003 Jun; 372(Pt 3):787-97. PubMed ID: 12628005
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor beta regulates parathyroid hormone-related protein expression in MDA-MB-231 breast cancer cells through a novel Smad/Ets synergism.
Lindemann RK; Ballschmieter P; Nordheim A; Dittmer J
J Biol Chem; 2001 Dec; 276(49):46661-70. PubMed ID: 11590145
[TBL] [Abstract][Full Text] [Related]
5. Splicing variant DeltaVII-Ets1 is downregulated in invasive Ets1-expressing breast cancer cells.
Ballschmieter P; Braig M; Lindemann RK; Nordheim A; Dittmer J
Int J Oncol; 2003 Apr; 22(4):849-53. PubMed ID: 12632078
[TBL] [Abstract][Full Text] [Related]
6. Importance of ets1 proto-oncogene for breast cancer progression.
Dittmer J; Vetter M; Blumenthal SG; Lindemann RK; Kölbl H
Zentralbl Gynakol; 2004 Aug; 126(4):269-71. PubMed ID: 15389378
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
Li H; Weinstein IB
Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
[TBL] [Abstract][Full Text] [Related]
8. Heregulin-induced apoptosis is mediated by down-regulation of Bcl-2 and activation of caspase-7 and is potentiated by impairment of protein kinase C alpha activity.
Le XF; Marcelli M; McWatters A; Nan B; Mills GB; O'Brian CA; Bast RC
Oncogene; 2001 Dec; 20(57):8258-69. PubMed ID: 11781840
[TBL] [Abstract][Full Text] [Related]
9. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
[TBL] [Abstract][Full Text] [Related]
10. Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells.
Radeff JM; Nagy Z; Stern PH
J Bone Miner Res; 2004 Nov; 19(11):1882-91. PubMed ID: 15476589
[TBL] [Abstract][Full Text] [Related]
11. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
12. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
13. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
Sivko GS; DeWille JW
J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
[TBL] [Abstract][Full Text] [Related]
14. Endothelial exposure to hypoxia induces Egr-1 expression involving PKCalpha-mediated Ras/Raf-1/ERK1/2 pathway.
Lo LW; Cheng JJ; Chiu JJ; Wung BS; Liu YC; Wang DL
J Cell Physiol; 2001 Sep; 188(3):304-12. PubMed ID: 11473356
[TBL] [Abstract][Full Text] [Related]
15. The biology of the Ets1 proto-oncogene.
Dittmer J
Mol Cancer; 2003 Aug; 2():29. PubMed ID: 12971829
[TBL] [Abstract][Full Text] [Related]
16. STAT1 and Nmi are downstream targets of Ets-1 transcription factor in MCF-7 human breast cancer cell.
Jung HH; Lee J; Kim JH; Ryu KJ; Kang SA; Park C; Sung K; Nam DH; Kang WK; Park K; Im YH
FEBS Lett; 2005 Jul; 579(18):3941-6. PubMed ID: 15996661
[TBL] [Abstract][Full Text] [Related]
17. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1.
Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K
Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984
[TBL] [Abstract][Full Text] [Related]
18. A spatiotemporally coordinated cascade of protein kinase C activation controls isoform-selective translocation.
Collazos A; Diouf B; Guérineau NC; Quittau-Prévostel C; Peter M; Coudane F; Hollande F; Joubert D
Mol Cell Biol; 2006 Mar; 26(6):2247-61. PubMed ID: 16508001
[TBL] [Abstract][Full Text] [Related]
19. Inositol hexaphosphate (IP6) blocks proliferation of human breast cancer cells through a PKCdelta-dependent increase in p27Kip1 and decrease in retinoblastoma protein (pRb) phosphorylation.
Vucenik I; Ramakrishna G; Tantivejkul K; Anderson LM; Ramljak D
Breast Cancer Res Treat; 2005 May; 91(1):35-45. PubMed ID: 15868430
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin and type IV collagen activate ERalpha AF-1 by c-Src pathway: effect on breast cancer cell motility.
Sisci D; Aquila S; Middea E; Gentile M; Maggiolini M; Mastroianni F; Montanaro D; Andò S
Oncogene; 2004 Nov; 23(55):8920-30. PubMed ID: 15467744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
